Body mass index and response to asthma therapy: Fluticasone propionate/salmeterol versus montelukast

Journal of Asthma

Volumn 47, Issue 1, 2010, Pages 76-82

  Camargo Jr , Carlos A ^a   Boulet, Louis Philippe ^b   Sutherland, E Rand ^c,d   Busse, William W ^e   Yancey, Steven W ^f   Emmett, Amanda H ^f   Ortega, Hector G ^f   Ferro, Thomas J ^f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c DEPARTMENT OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Asthma; Fluticasone propionate salmeterol; Montelukast; Obesity

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; BODY MASS; CONTROLLED STUDY; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PEAK EXPIRATORY FLOW; SCORING SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE; UNDERWEIGHT;

EID: 76149115897     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770900903338494     Document Type: Article

References (39)

1. World Health Organization Technical Report Series, No.894. Obesity: Preventing and managing the global epidemic. Report on a WHO consultation. Geneva: World Health Organization, 2000. BMI Classification update Retrieved 16 October 2008 from at http://apps.who.int/bmi/index.jsp? introPage=intro 3.html/.
2. Negri E, Pagano R, Decarli A, La Vecchia C. Body weight and the prevalence of chronic diseases. J Epidemiol Community Health 1988; 42:24-29.
3. Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001; 56:4-8.
4. Chen Y, Rennie D, Cormier Y, Dosman J. Sex specificity of asthma associated with objectively measured body mass index and waist circumference: The Humboldt study. Chest 2005; 128:3048-3054.
5. Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999; 159:2582-2588.
6. Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol 2004; 160:969-976. (Pubitemid 39488425)
7. Saint-Pierre P, Bourdin A, Chanez P, Daures JP, Godard P. Are overweight asthmatics more difficult to control? Allergy 2006; 61:79-84.
8. Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008; 63:14-20.
9. MosenDM, Schatz M, MagidDJ, CamargoCAJr. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008; 122:507-511.
10. Beckett WS, Jacobs DR Jr, Yu X, Iribarren C, Williams OD. Asthma is associated with weight gain in females but not males, independent of physical activity. Am J Respir Crit Care Med 2001; 164:2045-2050.
11. Chen Y, Dales R, Tang M, Krewski D. Obesity may increase the incidence of asthma in women but not in men: Longitudinal observations from the Canadian National Population Health Surveys. Am J Epidemiol 2002; 155:191-197.
12. Romieu I, Avenel V, Leynaert B, Kauffmann F, Clavel-Chapelon F. Body mass index, change in body silhouette, and risk of asthma in the E3N cohort study. Am J Epidemiol 2003; 158:165-174.
13. Ford ES, Mannino DM, Redd SC, Mokdad AH, Mott JA. Body mass index and asthma incidence among USA adults. Eur Respir J 2004; 24:740-744.
14. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006; 27:495-503.
15. Boulet, L-P, Franssen, E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101:2240-2247.
16. Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME. Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol 2009; 123:1328-1334.
17. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ,DeykinA,DiMango E, Fish JE, Ford JG, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.Am J Respir Crit Care Med 2007; 175:783-790.
18. Deykin A, Wechsler ME, Boushey HA, Chinchilli VM, Kunselman SJ, Craig TJ, DiMango E, Fahy JV, Kraft M, Leone F, et al. Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med 2007; 175:228-234.
19. Lemanske RF Jr, Sorkness CA, Mauger EA, Lazarus SC,Boushey HA, Fahy JV, Drazen JM, Chinchilli VM, Craig T, Fish JE, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: A randomized controlled trial. JAMA 2001; 285:2594-2603. (Pubitemid 32479899)
20. Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma. Ann Allergy Asthma Immunol 2002; 88:227-235. (Pubitemid 34165037)
21. Calhoun WJ, Nelson HS, Nathan RA, Pepsin PJ, Kalberg C, Emmett A, Rickard KA, Dorinsky P. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting b2-agonists alone. Am J Crit Care Med 2001; 164:759-763.
22. Koenig SM, Ostrom N, Pearlman D, Waitkus-Edwards K, Yancey S, Prillaman BA, Dorinsky P. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "steppeddown". J Asthma 2008; 45:681-687.
23. SAS40037: Results Summary Retrieved 16Oct 2008 from http://www. gskclinicalstudyregister. com/.
24. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175:661-666.
25. Eneli IU, Skybo T, Camargo CA Jr. Weight loss and asthma: A systematic review. Thorax 2008; 63:671-676.
26. Sutherland ER. Obesity and asthma. Immunol Allergy Clin NorthAm2008; 28:589-602.
27. Akerman MJ, Calacanis CM, Madsen MK. Relationship between asthma severity and obesity. J Asthma 2004; 41:521-526.
28. Black PN, Lawrence BJ, Goh KH, Barry MS. Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand. Eur J Clin Pharmacol 2000; 56:431-435.
29. Condemi JJ, Chervinsky P, Goldstein MF, Ford LB, Berger WE, Ayars GH, Rogenes PR, Edwards L, Pepsin PJ. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol 1997; 100:467-474.
30. Lessard A, Turcotte H, Cormier Y, Boulet LP. Obesity and asthma: A specific phenotype? Chest 2008; 134:317-323.
31. van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008; 63:570-574.
32. Bourdin A, Paganin F, Pŕefaut C, Kieseler D, Godard P, Chanez P. Nitrogen washout slope in poorly controlled asthma. Eur J Allergy Clin Immunol 2006; 61:85-89.
33. Cooper PR, Panettieri RA. Steroids completely reverse albuterol-induced 2-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 2008; 122:734-740.
34. Eickelberg O, Roth M, Lorx R, Bruce V, Rudiger J, Johnson M, Block LH. Ligand-independent activation of the glucocorticoid receptor by 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999; 274:1005-1010.
35. Pang L, Knox AJ. Synergistic inhibition by [beta]2-agonists and corticosteroids on tumor necrosis factor-[alpha]-induced interleukin-8 release from cultured human airway smooth muscle cells. Am J Respir Cell Mol Biol 2000; 23:79-85.
36. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008; 178:882-1687
37. Kaur M, Chivers JE, Giembycz MA, Newton R. Long-acting beta2- adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 2008; 73:203-214.
38. Global Initiative for Asthma retrieved 16 October 2008 from http://www. ginasthma.org.
39. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Full report 2007. Bethesda, MD: National Institutes of Health. August, 2007.